Medicines
SmPC of the 08/08/2013
SEDACOLLYRE CETYLPYRIDINIUM 0,25 per mille, eye drops in single-dose container
Composition
Cetylpyridinium (chloride) ............................................................ 0,10 mg
Sodium hydrogenphosphate dodecahydrate, potassium hydrogenphosphate, purified water q.s. 0,40 ml.
For one single-dose container
Dosage and administration
Topical use.
FOR OCULAR INSTILLATION
Instil 1 drop of eye drops into the lower conjunctival sac of the eye (or eyes) to be treated, gently pulling the lower eyelid downward and looking upward, 3 to 4 times a day, for 7 days on average.
Do not touch the eye or eyelids with the tip of the single-dose container.
Discard the single-dose container after use.
Contraindications
Hypersensitivity to any of the constituents of the eye drops or to another quaternary ammonium.
Warnings and precautions
Warnings
Do not inject, do not swallow.
The eye drops must not be administered by peri- or intra-ocular injection.
The treatment must not include several antiseptics.
The single-dose container must be discarded immediately after use and must not be kept for reuse during subsequent administrations.
Do not touch the eye with the tip of the single-dose container.
Precautions for use
- In case of hypersensitivity, discontinue the treatment.
- Treatment is usually limited to 7 days: intensive or prolonged use may cause alterations of the conjunctival and/or corneal epithelium. Caution is required particularly in cases of epithelial abnormalities.
- Avoid use in contact lens wearers: quaternary ammoniums may be absorbed by hydrophilic contact lenses and cause local intolerance.
- In case of concomitant treatment with another eye drops containing a different active ingredient, space the instillations by 15 minutes.
Interactions
Quaternary ammoniums are incompatible with fluorescein, pilocarpine nitrate, silver salts, boric acid, salicylates.
Fertility, pregnancy and breastfeeding
No teratogenesis study is available in animals.
In clinical practice, no particular malformative or foetotoxic effect has appeared to date.
However, the follow-up of pregnancies exposed to cetylpyridinium is insufficient to rule out any risk.
Consequently, as a precautionary measure, it is preferable not to use cetylpyridinium during pregnancy.
Adverse effects
Possibility of a transient irritation reaction, or local intolerance.
Risk of hypersensitivity reaction.
Pharmacodynamics
LOCAL ANTISEPTIC FOR OPHTHALMOLOGICAL USE (S = organs of sense).
Cetylpyridinium is a cationic antiseptic belonging to the class of quaternary ammoniums.
Pharmacokinetics
The wetting properties of quaternary ammoniums promote their passage through the cornea.
Special storage precautions
This medicine must be stored at a temperature below 25 °C.
This medicine must be discarded after use and not be kept after opening.
SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING
- To open a single-dose container, make a complete rotation of its end in order to break the seal.
- Invert the single-dose container in order to bring the contents down toward the open end.
- Instillation is then performed by gently squeezing the single-dose container.
- It is recommended to use a new single-dose container for each application to ensure instillation of an eye drop solution that is always sterile.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
PLACE LUCIEN AUVERT
77020 MELUN CEDEX
Tel: 01 64 87 20 00 https://www.cooper.fr/
Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.

